Pear Therapeutics, Inc. along with its affiliate, filed a motion for joint administration of its Chapter 11 bankruptcy case in the US Bankruptcy Court on April 7, 2023. As per the motion, the debtor seeks the joint administration of the case of its affiliate, Pear Therapeutics (US) Inc., with its own case for administrative and procedural purposes. Pear Therapeutics, Inc. has been proposed as the lead debtor.
Pear Therapeutics, Inc.
Equities
PEAR
US7047231052
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.87B | |
-10.62% | 37.8B | |
+40.49% | 37.61B | |
+29.92% | 31.32B | |
-9.78% | 27.4B | |
+12.34% | 26.32B | |
+41.53% | 14.07B | |
+31.49% | 12.5B | |
-7.40% | 11.23B |